Fumaric acid esters in combination with a 6-week course of narrow-band UVB provides for an accelerated response as compared to fumaric acid esters monotherapy in patients with moderate to severe plaque psoriasis: a randomized prospective clinical study

Tzaneva S, Geroldinger A, Trattner H, Tanew A

Br J Dermatol. 2017. doi: 10.1111/bjd.16106.

Patients that suffer from moderate to severe psoriasis have seen improvements with the use of fumaric acid esters (FAE); however, a slow onset of action has been noted. To improve this, adding the therapeutic option of narrowband ultraviolet B (NB UVB) light was effective. Results showed that adding the light therapy regimen to FAE solidified the response, and sped up the process. These outcomes also enhanced the patients’ quality of life.